UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 230

Sortiert nach

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Critical care (London, England), 2019-11, Vol.23 (1), p.374-374, Article 374

2019

Volltextzugriff (PDF)

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Critical care (London, England), 2017-08, Vol.21 (1), p.213-213, Article 213

2017

Volltextzugriff (PDF)

Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit

Journal of artificial organs, 2019-12, Vol.22 (4), p.341-344

2019

Volltextzugriff (PDF)

Adrenal function in sepsis: The retrospective Corticus cohort study

Critical care medicine, 2007-04, Vol.35 (4), p.1012-1018

2007

Volltextzugriff (PDF)

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

The New England journal of medicine, 2001-03, Vol.344 (10), p.699-709

2001

Volltextzugriff (PDF)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Volltextzugriff (PDF)

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Volltextzugriff (PDF)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

ERJ open research, 2023-01, Vol.9 (1), p.342

2023

Volltextzugriff (PDF)

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Critical care (London, England), 2020-06, Vol.24 (1), p.289-289, Article 289

2020

Volltextzugriff (PDF)

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Thorax, 2014-11, Vol.69 (11), p.1034-1042

2014

Volltextzugriff (PDF)

COVID-19 infection associated with autoimmune hemolytic anemia

Annals of hematology, 2020-07, Vol.99 (7), p.1679-1680

2020

Volltextzugriff (PDF)

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Critical care (London, England), 2020-07, Vol.24 (1), p.410-410, Article 410

2020

Volltextzugriff (PDF)

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Critical care (London, England), 2004-04, Vol.8 (2), p.R82-R90

2004

Volltextzugriff (PDF)

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1024-1034

2021

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19-Induced ARDS. Reply

The New England journal of medicine, 2024-01, Vol.390 (4), p.386-386

2024

Volltextzugriff (PDF)

New Agents in Development for Sepsis: Any Reason for Hope?

Drugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1751-1761

2020

Volltextzugriff (PDF)

Aerosol delivery during invasive mechanical ventilation: a systematic review

Critical care (London, England), 2017-10, Vol.21 (1), p.264-264, Article 264

2017

Volltextzugriff (PDF)

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2019-06, Vol.19 (6), p.620-630

2019

Volltextzugriff (PDF)

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Critical care medicine, 2018-09, Vol.46 (9), p.1436-1443

2018

Volltextzugriff (PDF)

The INHALE trial: multiple reasons for a negative result

The Lancet infectious diseases, 2020-07, Vol.20 (7), p.778-779

2020

Volltextzugriff (PDF)

Immunotherapies for COVID-19: lessons learned from sepsis

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.946-949

2020

Volltextzugriff (PDF)

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Critical care (London, England), 2018-01, Vol.22 (1), p.8-8, Article 8

2018

Volltextzugriff (PDF)

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Intensive care medicine, 2020-07, Vol.46 (7), p.1425-1437

2020

Volltextzugriff (PDF)

Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop

Intensive care medicine, 2020-05, Vol.46 (5), p.930-942

2020

Volltextzugriff (PDF)

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

PloS one, 2016-05, Vol.11 (5), p.e0156299-e0156299

2016

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(216)

Publikationsform

Sprache

Englisch
(227)
Japanisch
(26)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit

Adrenal function in sepsis: The retrospective Corticus cohort study

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

COVID-19 infection associated with autoimmune hemolytic anemia

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

Convalescent Plasma for Covid-19-Induced ARDS. Reply

New Agents in Development for Sepsis: Any Reason for Hope?

Aerosol delivery during invasive mechanical ventilation: a systematic review

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

The INHALE trial: multiple reasons for a negative result

Immunotherapies for COVID-19: lessons learned from sepsis

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

Aktive Filter

Suchergebnisse filtern